Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Molecular Genetics and Metabolism Reports|July 16, 2019
A longitudinal study of neurocognition and behavior in patients with Hurler-Scheie syndrome heterozygous for the L238Q mutationAlia Ahmed, Li Ou, Kyle Rudser, et al.
AMB Express|June 24, 2021
A GH89 human α-N-acetylglucosaminidase (hNAGLU) homologue from gut microbe Bacteroides thetaiotaomicron capable of hydrolyzing heparosan oligosaccharidesXiaohong Yang, Xiaoxiao Yang, Hai Yu, et al.
Osteoarthritis and Cartilage Open|October 13, 2023
Virtual performance measure in osteoarthritis: An innovative transformation of patient careHelen Razmjou, Suzanne Denis, Susan Robarts, et al.
Molecular Genetics and Metabolism|February 14, 2016
Elevated TNF-α is associated with pain and physical disability in mucopolysaccharidosis types I, II, and VILynda E Polgreen, Richard K Vehe, Kyle Rudser, et al.
Pediatric Research|September 5, 2013
Immune response to intrathecal enzyme replacement therapy in mucopolysaccharidosis I patientsMoin Vera, Steven Le, Shih-Hsin Kan, et al.
The Journal of Clinical Investigation|July 26, 2008
Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis IPatricia Dickson, Maryn Peinovich, Michael McEntee, et al.
American Journal of Medical Genetics. Part A|February 18, 2017
Intrathecal enzyme replacement therapy reverses cognitive decline in mucopolysaccharidosis type IIgor Nestrasil, Elsa Shapiro, Alena Svatkova, et al.
The Neuroradiology Journal|June 20, 2017
Novel region of interest interrogation technique for diffusion tensor imaging analysis in the canine brainJonathan Y Li, Dana M Middleton, Steven Chen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 14, 2011
Glycosaminoglycan storage in neuroanatomical regions of mucopolysaccharidosis I dogs following intrathecal recombinant human iduronidaseAgnes Chen, Carole Vogler, Michael McEntee, et al.
Molecular Genetics and Metabolism|July 17, 2024
Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic MucopolysaccharidosesJoseph Muenzer, Carole Ho, Heather Lau, et al.
Pageof 5